Accord’s Canada business operation was established in 2007 and is based out of Montreal, with a regional presence in Toronto and a research facility in Quebec City. We strive to supply and make available the high quality and yet affordable medicines to the Canadian healthcare sector. Towards this, we have established several strategic alliances with key partners to bring our products into Canada. Our highly experienced and dedicated team is focused on serving both the hospital and retail sectors. Accord is in the process of expanding its commercial operations in Canada to promote, market and distribute its large and expanding product portfolio.

Accord’s current Canada portfolio consists of 18 approved products and 14 product submissions awaiting approval from Health Canada. Our products are available in a multitude of different formats including Tablets (standard, film-coated, effervescent, sustained release), Capsules and Injectables (powder and solution vials, ampoules). Our current product portfolio is focused on multiple therapeutic segments like Oncology & Supportive Therapies, Cardio-Vascular, Neurology and Anti-Diabetics, etc.